In Reply
- PMID: 29968562
- PMCID: PMC6050435
- DOI: 10.3238/arztebl.2018.0417b
In Reply
Comment on
-
Some Necessary Additional Points.Dtsch Arztebl Int. 2018 Jun 15;115(24):417. doi: 10.3238/arztebl.2018.0417a. Dtsch Arztebl Int. 2018. PMID: 29968561 Free PMC article. No abstract available.
References
-
- Engert A, Haverkamp H, Kobe C, et al. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin‘s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet. 2012;379:1791–1799. - PubMed
-
- Galper SL, Yu JB, Mauch PM, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117:412–418. - PubMed
-
- Radford J, Illidge T, Counsell N, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin‘s lymphoma. N Engl J Med. 2015;372:1598–1607. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources